CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Tan Aik Na Director | Option exercise 10b5-1 | +45,000 | $4.59 | $206K | 70,400 |
| 2025-12-08 | Tan Aik Na Director | Sale 10b5-1 | −20,000 | $12.75 | $255K | 50,400 |
| 2025-12-08 | Tan Aik Na Director | Sale 10b5-1 | −25,000 | $15.00 | $375K | 25,400 |
| 2025-12-08 | Tan Aik Na Director | Option exercise 10b5-1 | +21,000 | $3.50 | $74K | 46,400 |
| 2025-12-08 | Tan Aik Na Director | Sale 10b5-1 | −21,000 | $12.75 | $268K | 25,400 |
| 2025-12-08 | Tan Aik Na Director | Option exercise 10b5-1 | +21,000 | $5.97 | $125K | 46,400 |
| 2025-12-08 | Tan Aik Na Director | Sale 10b5-1 | −21,000 | $12.75 | $268K | 25,400 |
| 2025-12-08 | Tan Aik Na Director | Option exercise · Share Option (right to buy) 10b5-1 | −32,230 | 0 | ||
| 2025-12-08 | Tan Aik Na Director | Option exercise · Share Option (right to buy) 10b5-1 | −45,000 | 0 | ||
| 2025-12-08 | Tan Aik Na Director | Option exercise · Share Option (right to buy) 10b5-1 | −21,000 | 0 | ||
| 2025-12-08 | Tan Aik Na Director | Option exercise · Share Option (right to buy) 10b5-1 | −21,000 | 0 | ||
| 2025-12-08 | Verdine Gregory L. Director | Sale 10b5-1 | −12,020 | $13.09 | $157K | 283,197 |
| 2025-12-08 | Verdine Gregory L. Director | Sale 10b5-1 | −7,980 | $14.05 | $112K | 275,217 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +28,125 | $3.14 | $88K | 53,125 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −28,125 | $14.50 | $408K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +107,400 | $3.87 | $416K | 132,400 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −107,400 | $14.56 | $1.6M | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +45,882 | $4.75 | $218K | 70,882 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −45,882 | $14.50 | $665K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +9,375 | $3.14 | $29K | 34,375 |
Page 5 of 13 · 255 trades